Patent · US Active

Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

US9475779B2 · kind B2 · utility

0Cited by

4References

14Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Thorsten Oost · Biberach an der Riß, DE
Ralf Anderskewitz · Laupheim, DE
Christian Gnamm · Biberach an der Riß, DE
Holger Hoesch · Biberach an der Riß, DE
Gerd Morschhaeuser · Biberach, DE
Stefan Peters · Biberach an der Riß, DE
Uwe Ries · Biberach an der Riß, DE

Key dates

Filing date	Jul 27, 2015
Grant date	Oct 25, 2016
Priority date	—
Expiry date	Jul 27, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Substituted bicyclic dihydropyrimidinones of formula 1which are inhibitors of neutrophil elastase and useful as medicaments for the treatment of, inter alia, COPD. An exemplary compound is:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.